RADICAVA ORS

Serial Number 79334971
Registration 7082599
700

Registration Progress

Application Filed
Dec 23, 2021
Under Examination
Approved for Publication
Apr 4, 2023
Published for Opposition
Apr 4, 2023
Registered
Jun 20, 2023

Trademark Image

RADICAVA ORS

Basic Information

Serial Number
79334971
Registration Number
7082599
Filing Date
December 23, 2021
Registration Date
June 20, 2023
Published for Opposition
April 4, 2023
Drawing Code
3000

Status Summary

Current Status
Active
Status Code
700
Status Date
Jun 20, 2023
Registration
Registered
Classes
005

Rights Holder

Mitsubishi Tanabe Pharma Corporation

03
Address
3-2-10, Dosho-machi,
Chuo-ku, Osaka-shi Osaka 541-8505
JP

Ownership History

Mitsubishi Tanabe Pharma Corporation

Original Applicant
03
JP

Mitsubishi Tanabe Pharma Corporation

Owner at Publication
03
JP

Mitsubishi Tanabe Pharma Corporation

Original Registrant
03
JP

Legal Representation

Attorney
Jeffrey L. Costellia

USPTO Deadlines

Next Deadline
1418 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-06-20)
Due Date
June 20, 2029
Grace Period Ends
December 20, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

30 events
Date Code Type Description Documents
Oct 16, 2023 FINV P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Sep 22, 2023 FIMP P FINAL DISPOSITION PROCESSED Loading...
Sep 22, 2023 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Sep 20, 2023 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Jun 20, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jun 20, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Apr 4, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 4, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 15, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 23, 2023 PBSR Z WITHDRAWN FROM PUB - SENIOR ATTORNEY REQUEST Loading...
Feb 23, 2023 ZZZX Z PREVIOUS ALLOWANCE COUNT WITHDRAWN Loading...
Feb 23, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Feb 23, 2023 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Feb 23, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Feb 23, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Feb 23, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 15, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 3, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 2, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Feb 2, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 4, 2023 RFNP P REFUSAL PROCESSED BY IB Loading...
Dec 14, 2022 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Dec 13, 2022 RFRR P REFUSAL PROCESSED BY MPU Loading...
Sep 29, 2022 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Sep 28, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 28, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 22, 2022 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Mar 17, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 16, 2022 LIMI I LIMITATION FROM ORIGINAL APPLICATION ENTERED Loading...
Mar 3, 2022 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of central nervous system diseases; pharmaceutical preparations for protection against free radicals; pharmaceutical preparations for removing free radicals from the human bodies; neuroprotective medicines; pharmaceutical preparations for the treatment of amyotrophic lateral sclerosis (ALS)
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Design Mark
The mark consists of the wording RADICAVA ORS in stylized font with a design of three curved lines below the wording ORS.

Classification

International Classes
005